The plant kingdom as a source of anti-ulcer remedies.

Department of Experimental Pharmacology, University of Naples 'Federico II', via D. Montesano 49, 80131 Naples, Italy.
Phytotherapy Research (Impact Factor: 2.4). 01/2001; 14(8):581-91. DOI: 10.1002/1099-1573(200012)14:83.0.CO;2-S
Source: PubMed

ABSTRACT Phytogenic agents have traditionally been used by herbalists and indigenous healers for the prevention and treatment of peptic ulcer. This article reviews the anti-acid/anti-peptic, gastro-protective and/or anti-ulcer properties of the most commonly employed herbal medicines and their identified active constituents. Botanical compounds with anti-ulcer activity include flavonoids (i.e. quercetin, naringin, silymarin, anthocyanosides, sophoradin derivatives) saponins (i.e. from Panax japonicus and Kochia scoparia), tannins (i.e. from Linderae umbellatae), gums and mucilages (i.e. gum guar and myrrh). Among herbal drugs, liquorice, aloe gel and capsicum (chilli) have been used extensively and their clinical efficacy documented. Also, ethnomedical systems employ several plant extracts for the treatment of peptic ulcer. Despite progress in conventional chemistry and pharmacology in producing effective drugs, the plant kingdom might provide a useful source of new anti-ulcer compounds for development as pharmaceutical entities or, alternatively, as simple dietary adjuncts to existing therapies.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This study reports a comprehensive investigation on the presence of flavonoids, limonoids and dietary fiber determined by HPLC in all the by-products of the industrial transforma- tion of orange. Seeds were the richest source of bioactive molecules, with flavanones being the most abundant, followed by phenolic acids (238 mg/kg). However, p-hydroxybenzoic acid and caffeic acid were highly represented also in the exhausted peels and pulps (560 mg/ kg). Limonoids were determined exclusively in seeds.Among all the by-products it was found that waste water is extremely rich of hesperidin (19,500 mg/kg). For this reason an only eco- friendly preparative HPLC method for the recovery and purification of hesperidin from waste water was developed. Dietary fiber was determined in exhausted peels and pulps which resulted to be rich sources of insoluble dietary fiber.The results show that the by-products here investigated represent important sources of nutraceuticals as ingredients useful for functional food preparation
    Journal of Functional Foods 01/2015; 12:150-157. · 4.48 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Research on plants has as its purpose the development of new drugs to treat diseases that affect humans. The increasing prevalence of multidrug resistant strains of bacteria and the recent appearance of strains with reduced susceptibility to antibiotics raises the specter of untreatable bacterial infections and adds urgency to the search for brand new infection-fighting strategies. Current advancements in drug discovery technology and search for new drugs from plants have always been of great interest for the scientists working in this field. The biological activity of methanolic extracts of Castela texana and Stenocereus marginatus was evaluated in vitro in the growth of Helicobacter pylori, both extracts inhibited the growth, but the methanolic extract of S. marginatus completely inhibited biofilm formation; this structure is important for the protection of H. pylori and increased resistance to antimicrobial agents. The toxicity was determined in Artemia salina; the methanolic extract of S. marginatus is less toxic than the extract of C. texana. The phytochemical analysis of the methanolic extract of S. marginatus revealed that potential secondary metabolites with anti-H. pylori activity are flavones, sesquiterpene lactones and alkaloids. As a result, future research should be conducted to obtain pure substances from S. marginatus for possible treatment of H. pylori.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This study was performed to determine the anti-ulcer effects of ethanol extract of Parkia speciosa on Indomethacin induced peptic ulcer in Albino rats. Rats of female sex weighing between 150 g-200 g were used. Rats were divided into six groups with six rats in each group. Omeprazole (20 mg/kg) were used as a standard drug for this study. Parkia speciosa extract were given in three different doses comprised of 100 mg/kg, 200 mg/kg and 400 mg/kg. Pre-treatment were done for 14 days and at the end of the 14th day, rats were kept fasted for 24 hours before administration of Indomethacin at 30 mg/kg. Administration of drugs was done orally. At the end of the study, rats were sacrificed and stomachs were open and stored in 10% formalin solution. The acidity of gastric juice, gastric mucosal lesion and histological changes were studied. Extracts of Parkia speciosa showed a significant (P<0.05) reduction in acidity of gastric juice as compared to the ulcer control group. Two doses of Parkia speciosa ethanol extract that is 200 mg/kg and 400 mg/kg showed significant (P<0.05) reduction in lesion length as compared to ulcer control group. Histological studies showed lesser collagen and fibrosis were present in tissue from rats treated with Parkia speciosa extract compared to tissues of rats from ulcer control group. INDRODUCTION: The ulcer is the open sore in the lining of the stomach or intestine, similar to mouth ulcers (stomatitis) and skin ulcer. Gastric ulcer is the ulcer which occurs in the stomach. Duodenal ulcer is the ulcer that occurs in the first part of the intestine. Peptic ulcer is the term used for either of the ulcers or both ulcers 1. The most common gastrointestinal disease is peptic ulcer disease (PUD) 2. Peptic ulcer occurs due to the reaction of acid and pepsin which is the digestive enzyme present in the stomach towards the mucosal lining of the stomach which leads to the excoriation of it 3 .
    International Journal of Pharmaceutical Sciences and Research 02/2015; 6(6 2):895-902. DOI:10.13040/IJPSR.0975-8232.6(2).1000-08 · 0.01 Impact Factor

Full-text (3 Sources)

Available from
Dec 17, 2014